Related Experiment Video
Updated: Jan 3, 2026

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice
Published on: January 2, 2013
The Liver-Stage Plasmodium Infection Is a Critical Checkpoint for Development of Experimental Cerebral Malaria
Yuko Sato1,2, Stefanie Ries3, Werner Stenzel4
1Parasitology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
Abstract:
Cerebral malaria is a life-threatening complication of malaria in humans, and the underlying pathogenic mechanisms are widely analyzed in a murine model of experimental cerebral malaria (ECM). Here, we show abrogation of ECM by hemocoel sporozoite-induced infection of a transgenic Plasmodium berghei line that overexpresses profilin, whereas these parasites remain fully virulent in transfusion-mediated blood infection. We, thus, demonstrate the importance of the clinically silent liver-stage infection for modulating the onset of ECM. Even though both parasites triggered comparable splenic immune cell expansion and accumulation of antigen-experienced CD8+ T cells in the brain, infection with transgenic sporozoites did not lead to cerebral vascular damages and suppressed the recruitment of overall lymphocyte populations. Strikingly, infection with the transgenic strain led to maintenance of CD115+Ly6C+ monocytes, which disappear in infected animals prone to ECM. An early induction of IL-10, IL-12p70, IL-6, and TNF at the time when parasites emerge from the liver might lead to a diminished induction of hepatic immunity. Collectively, our study reveals the essential role of early host interactions in the liver that may dampen the subsequent pro-inflammatory immune responses and influence the occurrence of ECM, highlighting a novel checkpoint in this fatal pathology.
Insights
Early liver-stage interactions in cerebral malaria (ECM) are crucial. Modulating these interactions with transgenic parasites prevents ECM pathology by altering immune cell responses, revealing a novel checkpoint.
Area of Science:
- Immunology
- Infectious Diseases
- Pathology
Background:
- Cerebral malaria (ECM) is a severe complication of malaria, with its mechanisms studied in murine models.
- Understanding ECM pathogenesis is vital for developing effective treatments.
Purpose of the Study:
- To investigate the role of liver-stage Plasmodium infection in modulating experimental cerebral malaria (ECM).
- To identify host-parasite interactions during the liver stage that influence ECM development.
Main Methods:
- Utilized a transgenic Plasmodium berghei parasite line overexpressing profilin for hemocoel sporozoite-induced infection.
- Compared virulence and pathological outcomes with transfusion-mediated blood infection.
- Analyzed splenic immune cell expansion, CD8+ T cell accumulation, lymphocyte recruitment, and monocyte populations (CD115+Ly6C+) in the brain.
- Measured early cytokine induction (IL-10, IL-12p70, IL-6, TNF) during parasite liver-stage emergence.
Main Results:
- Transgenic parasites abrogated ECM despite full virulence in blood infections, highlighting the liver stage's importance.
- ECM was prevented despite comparable splenic immune cell expansion and brain CD8+ T cell accumulation.
- Cerebral vascular damage was absent, and overall lymphocyte recruitment was suppressed in transgenic infections.
- Maintenance of CD115+Ly6C+ monocytes was observed in transgenic infections, unlike ECM-prone infections.
- Early induction of specific cytokines (IL-10, IL-12p70, IL-6, TNF) correlated with diminished hepatic immunity.
Conclusions:
- Clinically silent liver-stage Plasmodium infections critically modulate the onset of experimental cerebral malaria (ECM).
- Early host-parasite interactions in the liver can dampen subsequent pro-inflammatory responses, influencing ECM occurrence.
- This study identifies a novel checkpoint in ECM pathogenesis related to early hepatic immunity modulation.
More Related Videos
08:20In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
09:04In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017